Lutetium texaphyrin (lu-tex): A potential new agent for ocular fundus angiography and photodynamic therapy

American Journal of Ophthalmology

Volumn 129, Issue 3, 2000, Pages 353-362

  Blumenkranz, Mark S ^a   Woodburn, Kathryn W ^b   Qing, Fan ^a,b,c,d   Verdooner, Steven ^c   Kessel, David ^d   Miller, Richard ^a,b,c,d  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b PHARMACYCLICS INC   (United States)

^c Ophthalmic Imaging Systems   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUTETIUM; LUTETIUM TEXAPHYRIN; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOROID VASCULARIZATION; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; MICROSCOPY; NONHUMAN; OPHTHALMOSCOPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RABBIT; RETINA BLOOD VESSEL;

ANIMALS; CHOROID; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; FLUORESCEIN; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; INDOCYANINE GREEN; LUTETIUM; MALE; METALLOPORPHYRINS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RABBITS; RETINAL NEOVASCULARIZATION; RETINAL VESSELS;

EID: 0033995123     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00462-6     Document Type: Article

References (42)

1. Occult choroidal neovascularization influence on visual outcome in age related macular degeneration . Arch Ophthalmol. 114:1996;400-412.
2. Guyer D., Yannuzzi L., Slakter J., et al. Classification of choroidal neovascularization by digital indocynanine green video-angiography. Angiography Ophthalmol. 103:1996;2054-2060.
3. Laser photocoagulation of subfoveal neovascular lesions of age related macular degeneration, updating findings from two clinical trials. Arch Ophthalmol. 111:1993;1200-1209.
4. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age related macular degeneration the influence of initial lesion size and visual acuity . Arch Ophthalmol. 112:1994;480-488.
5. Guyer D., Puliafito J., Mones E., et al. Digital indocyanine-green angiography in chorioretinal disorders. Ophthalmology. 99:1992;287-291.
6. Guyer D., Yannuzzi L., Ladas I., et al. Indocyanine green-guided laser photocoagulation of focal spots at the edge of plaques of choroidal neovascularization. Arch Ophthalmol. 114:1996;693-697.
7. Orlock D.A. ICG angiograms using conventional fundus cameras. Yannuzzi L., Flower R., Slakter J. Indocyanine green angiography. 1997;50-56 Mosby Co, St Louis, Missouri.
8. Kramer M., Miller J., Michaud N., et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Ophthalmology. 103:1995;427-438.
9. Miller J., Walsh A., Kramer M., et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol. 113:1995;810-818.
10. Slakter J., Yannuzzi L., Sorenson J., et al. A pilot study of indocyanine green videoangiography-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol. 112:1994;465-472.
11. Flower R. Physical optics concepts related to obtaining and interpreting ICG angiograms. Yannuzzi L., Flower R., Slakter J. Indocyanine green angiography. 1997;105-118 Mosby Co, St Louis, Missouri.
12. Henderson B.W., Dougherty T.J. How does photodynamic therapy work? Photochem Photobiol. 55:1992;145-157.
13. Roberts W., Hasan T. Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents. Cancer Res. 52:1992;924-930.
14. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin one-year results of two randomized clinical trials - TAP report 1 . Arch Ophthalmol. 117:1999;1329-1345.
15. Thomas EL, Rosen R, Murphy R, et al. Visual acuity stabilizes after a single treatment with SnET2-photodynamic therapy in patients with subfoveal choroidal neovascularization (ARVO abstract 2112). Invest Ophthalmol Vis Sci 1999;40:S401.
16. Sessler J.L., Hemmi G., Mody T.D., et al. Texaphyrins synthesis and applications . Am Chem Soc Accounts Chem Res. 27:1994;43-50.
17. Young S., Woodburn K., Wright M., et al. Lutetium texaphyrin (PCI-0123) a near-infrared water-soluble photosensitizer . Photochem Photobiol. 63:1996;892-897.
18. Woodburn K., Fan Q., Miles D., et al. Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model. Photochem Photobiol. 65:1997;410-415.
19. Woodburn KW, Fan Q, Young SW. Photoangioplasty following intravenous lutetium texaphyrin: a far red, light activated photodynamic agent that selectively accumulates in atheroma. Circulation 1997;96:I-135.
20. Renschler M.F., Yuen A.R., Panella T.J., et al. Photodynamic therapy trials with lutetium texaphyrin (lu-tex) in patients with locally recurrent breast cancer. Proc SPIE. 3247:1988;35-39.
21. Wieman TJ, Panella T, Lustig R, et al. Photodynamic therapy (PDT) of locally recurrent breast cancer (LRBC) with lutetium texaphyrin (lutrin). Am Soc Clin Oncol 1999;111a:418.
22. Rockson SG, Kramer P, Razavi M, et al. Photoangioplasty of human atherosclerosis with lutetium texaphyrin (Antrin™). Photochem Photobiol 1999;69S:49S.
23. Ryan S. Subretinal neovascularization natural history of an experimental model . Arch Ophthalmol. 100:1982;1804-1809.
24. Woodburn K., Kessel D. Effect of density gradients on binding of photosensitizing agents to plasma proteins. Int J Biochem Cell Biol. 7:1995;499-506.
25. Graham KB, Arbour JD, Connolly EJ, et al. Digital angiography using lutetium texaphyrin in a monkey model of choroidal neovascularization. (ARVO abstract 2117). Invest Ophthalmol Vis Sci 1999;40:S402.
26. Delori F., Ben-Sira I., Trempe C. Fluorescein angiography with an optimized filter combination. Am J Ophthalmol. 82:1976;559-566.
27. Novotny H., Alvis D. A method of photographing fluorescence in circulating blood in the human retina. Circulation. 24:1961;82-86.
28. Ham W., Sliney D. Retinal sensitivity to damage from short wavelength light. Nature. 260:1976;153-155.
29. Hochheimer B., Spring S. Angiography of the retina with indocyanine green. Arch Ophthalmol. 86:1971;564-565.
30. Reichel E., Puliafitto J. Indocynanine green dye enhanced diode photocoagulation of well defined subfoveal choroidal neovascular membranes. (ARVO abstract) Invest Ophthalmol Vis Sci. 34:1993;1164.
31. Landsman M.L.S., Kwant G., Mook G.A., Zijlstra W.G. Light-absorbing properties, stability, and spectral stabilization of indocynanine green. J Appl Physiol. 40:1976;575-583.
32. Door M., Pollack G. Specific assay for the quantitation of indocynanine green with fluorescein detection. Pharmaceut Sci. 78:1989;328-333.
33. Fingar V.H., Haydon P.S., Taber S.W., Wieman T.J. Assessment of selected damage to tumor vasculature after PDT. Photochem Photobiol. 67S:1998;25S.
34. Blumenkranz M.S., Woodburn K., Verdooner S. Lutetium texaphyrin angiography a new method for the evaluation and treatment of retinal and choroidal vascular disorders . (ARVO abstract 2142) Invest Ophthalmol Vis Sci. 39:1998;S468.
35. Grossweiner L.I., Bilgin M.D., Berdusis P., Mody T.D. Singlet oxygen generation by metallotexaphyrins. Photochem Photobiol. 70:1999;138-145.
36. Fingar V.H., Wiemann T.J., Taber S.W. Use of scanning Doppler velocimetry to monitor vascular changes during photodynamic therapy. SPIE. 3592:1999;14-19.
37. Denekamp J. Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis Rev. 9:1990;267-282.
38. Schmidt U., Birngruber R., Hasan T. Selective occlusion of ocular neovascularization by photodynamic therapy. Ophthalmology. 89:1992;391-394.
39. Rutledge J., Curry F., Blanche P., Krauss R. Solvent drag of LDL across mammalian endothelial barriers with increased permeability. Am J Physiol. 268:1995;H1982-H1991.
40. Schnitzer J., Carley W., Palade G. Albumin interacts with a 60-kDa microvascular endothelial glycoprotein. Proc Natl Acad Sci. 85:1988;6773-6777.
41. Haimovici R., Kramer M., Miller J., et al. Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. Curr Eye Res. 16:1997;83-90.
42. Arbour J.D., Connolly E.J., Graham K., et al. Photodynamic therapy of experimental choroidal neovascularization in a monkey model using intravenous infusion of lutetium texaphyrin. (ARVO abstract 2111) Invest Ophthalmol Vis Sci. 40:1999;S401.